Title : Tacrolimus Inhibits TNF-α/IL-17A-Produced pro-Inflammatory Effect on Human Keratinocytes by Regulating IκBζ.

Pub. Date : 2020 Apr

PMID : 31838663






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tacrolimus Inhibits TNF-alpha/IL-17A-Produced pro-Inflammatory Effect on Human Keratinocytes by Regulating IkappaBzeta. Tacrolimus interleukin 17A Homo sapiens
2 This study aimed to investigate the potential regulatory effect of tacrolimus on TNF-alpha/ IL-17A-costimulated human keratinocytes in the mimic psoriatic microenvironment. Tacrolimus interleukin 17A Homo sapiens
3 Tacrolimus significantly inhibited TNF-alpha/IL-17A-induced IL-36gamma, CCL-20, IL-1beta, and S100-A9 expression at gene level and IL-36gamma and CCL-20 expression at protein level. Tacrolimus interleukin 17A Homo sapiens
4 We further discovered TNF-alpha/IL-17A induced significant IkappaBzeta mRNA and protein expression in NHKs, which could be inhibited by tacrolimus. Tacrolimus interleukin 17A Homo sapiens
5 Tacrolimus can inhibit pro-inflammatory synergistic action of TNF-alpha/IL-17A on human keratinocytes by regulating IkappaBzeta expression. Tacrolimus interleukin 17A Homo sapiens